UPDATE: JPMorgan Starts Karuna Therapeutics Inc. (KRTX) at Overweight
Tweet Send to a Friend
(Updated - September 30, 2021 5:02 AM EDT)
JPMorgan analyst Cory Kasimov initiates coverage on Karuna Therapeutics Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Cory Kasimov initiates coverage on Karuna Therapeutics Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
